Celanese Corp Del Financials
Celanese Corp Del (CE) reported $9.5B in revenue for fiscal year 2025, down 7.1% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Persistent cash generation amid accounting losses now coexists with a balance sheet increasingly dependent on leverage.
In FY2025, operating cash flow was$1.15B while net income was-$1.17B , so the reported loss did not translate into equivalent cash erosion. Unlike FY2023, free cash flow still reached$803M after$343M of capital spending, indicating that non-cash or below-operating items are materially widening the gap between earnings and cash.
The deterioration is operating, not merely financial: revenue fell to
Leverage rose to 2.8x from 1.7x in FY2023 while long-term debt declined, indicating that equity erosion rather than borrowing growth drove the balance-sheet shift. The 1.5x current ratio masks a thinner cash cushion:
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Celanese Corp Del's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Celanese Corp Del has an operating margin of -8.2%, meaning the company loses $8 on every $100 of revenue. This results in a profitability score of 27/100. This is down from -7.0% the prior year.
Celanese Corp Del's revenue declined 7.1% year-over-year, from $10.3B to $9.5B. This contraction results in a growth score of 14/100.
Celanese Corp Del has elevated debt relative to equity (D/E of 2.81), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 22/100, reflecting increased financial risk.
Celanese Corp Del's current ratio of 1.55 indicates adequate short-term liquidity, earning a score of 42/100. The company can meet its near-term obligations, though with limited headroom.
Celanese Corp Del has a free cash flow margin of 8.4%, earning a moderate score of 62/100. The company generates positive cash flow after capital investments, but with room for improvement.
Celanese Corp Del posts a -28.8% return on equity (ROE), meaning it loses $29 for every $100 of shareholders' equity. This results in a returns score of 29/100. This is up from -30.1% the prior year.
Celanese Corp Del scores 1.24, below the 1.81 distress threshold. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Celanese Corp Del passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
Celanese Corp Del reported a net loss of $1.2B while generating $1.1B in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Celanese Corp Del reported an operating loss of $786.0M against $701.0M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Celanese Corp Del generated $9.5B in revenue in fiscal year 2025. This represents a decrease of 7.1% from the prior year.
Celanese Corp Del's EBITDA was -$26.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 132.1% from the prior year.
Celanese Corp Del reported -$1.2B in net income in fiscal year 2025. This represents an increase of 24.4% from the prior year.
Celanese Corp Del earned -$10.64 per diluted share (EPS) in fiscal year 2025. This represents an increase of 24.6% from the prior year.
Cash & Balance Sheet
Celanese Corp Del generated $803.0M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 51.2% from the prior year.
Celanese Corp Del held $1.3B in cash against $11.4B in long-term debt as of fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
Celanese Corp Del's gross margin was 20.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 2.3 percentage points from the prior year.
Celanese Corp Del's operating margin was -8.2% in fiscal year 2025, reflecting core business profitability. This is down 1.2 percentage points from the prior year.
Celanese Corp Del's net profit margin was -12.2% in fiscal year 2025, showing the share of revenue converted to profit. This is up 2.8 percentage points from the prior year.
Celanese Corp Del's ROE was -28.8% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 1.3 percentage points from the prior year.
Capital Allocation
Celanese Corp Del invested $125.0M in research and development in fiscal year 2025. This represents a decrease of 3.8% from the prior year.
Celanese Corp Del invested $343.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 21.1% from the prior year.
Not reported for fiscal year 2025.
CE Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.7B | $9.5B-7.1% | $10.3B-6.0% | $10.9B+13.0% | $9.7B+13.3% | $8.5B+51.0% | $5.7B-10.2% | $6.3B-12.0% | $7.2B+16.5% | $6.1B+13.9% | $5.4B-5.0% | $5.7B-16.6% | $6.8B+4.5% | $6.5B+1.4% | $6.4B-5.1% | $6.8B |
| Cost of Revenue | $7.7B | $7.6B-4.3% | $7.9B-4.9% | $8.3B+14.4% | $7.3B+24.6% | $5.9B+34.2% | $4.4B-7.0% | $4.7B-9.5% | $5.2B+12.0% | $4.6B+16.2% | $4.0B-8.5% | $4.4B-16.0% | $5.2B+0.8% | $5.1B-1.8% | $5.2B-1.7% | $5.3B |
| Gross Profit | $2.0B | $2.0B-16.4% | $2.3B-9.6% | $2.6B+8.5% | $2.4B-11.3% | $2.7B+107.4% | $1.3B-19.5% | $1.6B-18.6% | $2.0B+30.5% | $1.5B+7.5% | $1.4B+6.6% | $1.3B-18.4% | $1.6B+18.4% | $1.4B+15.6% | $1.2B-17.6% | $1.4B |
| R&D Expenses | $120.0M | $125.0M-3.8% | $130.0M-11.0% | $146.0M+30.4% | $112.0M+30.2% | $86.0M+16.2% | $74.0M+10.4% | $67.0M-6.9% | $72.0M-1.4% | $73.0M-6.4% | $78.0M-34.5% | $119.0M+38.4% | $86.0M+1.2% | $85.0M-18.3% | $104.0M+8.3% | $96.0M |
| SG&A Expenses | $931.0M | $899.0M-13.0% | $1.0B-4.1% | $1.1B+30.7% | $824.0M+30.2% | $633.0M+31.3% | $482.0M-0.2% | $483.0M-11.5% | $546.0M+10.1% | $496.0M+31.2% | $378.0M-25.3% | $506.0M-33.2% | $758.0M+143.7% | $311.0M-62.5% | $830.0M+54.9% | $536.0M |
| Operating Income | -$692.0M | -$786.0M-9.2% | -$720.0M-143.2% | $1.7B+20.8% | $1.4B-29.2% | $1.9B+193.1% | $664.0M-20.4% | $834.0M-37.5% | $1.3B+55.7% | $857.0M-8.2% | $934.0M+186.5% | $326.0M-57.0% | $758.0M-49.7% | $1.5B+761.7% | $175.0M-74.6% | $690.0M |
| Interest Expense | $723.0M | $701.0M+3.7% | $676.0M-6.1% | $720.0M+77.8% | $405.0M+345.1% | $91.0M-16.5% | $109.0M-5.2% | $115.0M-8.0% | $125.0M+2.5% | $122.0M+1.7% | $120.0M+0.8% | $119.0M-19.0% | $147.0M-14.5% | $172.0M-7.0% | $185.0M-16.3% | $221.0M |
| Income Tax | $22.0M | -$90.0M-117.8% | $507.0M+163.8% | -$795.0M-62.6% | -$489.0M-248.2% | $330.0M+33.6% | $247.0M+99.2% | $124.0M-57.5% | $292.0M+37.1% | $213.0M+74.6% | $122.0M-39.3% | $201.0M-36.0% | $314.0M-38.2% | $508.0M+1023.6% | -$55.0M-136.9% | $149.0M |
| Net Income | -$1.2B | -$1.2B+24.4% | -$1.5B-179.4% | $1.9B+2.6% | $1.9B+0.2% | $1.9B-4.8% | $2.0B+133.0% | $852.0M-29.4% | $1.2B+43.2% | $843.0M-6.3% | $900.0M+196.1% | $304.0M-51.3% | $624.0M-43.3% | $1.1B+196.0% | $372.0M-38.7% | $607.0M |
| EPS (Diluted) | — | -$10.64+24.6% | -$14.11-179.4% | $17.76+2.4% | $17.34+2.8% | $16.86+0.7% | $16.75+144.9% | $6.84-23.2% | $8.91+46.3% | $6.09-1.5% | $6.18+209.0% | $2.00-50.0% | $4.00-42.1% | $6.91+196.6% | $2.33-39.0% | $3.82 |
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
CE Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $21.7B-5.0% | $22.8B-14.1% | $26.6B+1.2% | $26.3B+119.4% | $12.0B+9.8% | $10.9B+15.1% | $9.5B+1.8% | $9.3B-2.4% | $9.5B+14.1% | $8.4B-2.7% | $8.6B-2.4% | $8.8B-2.5% | $9.0B+0.2% | $9.0B+5.7% | $8.5B |
| Current Assets | $5.7B+11.1% | $5.1B-17.6% | $6.2B-5.9% | $6.6B+73.7% | $3.8B+1.2% | $3.8B+36.1% | $2.8B-3.8% | $2.9B+2.9% | $2.8B+12.9% | $2.5B-11.3% | $2.8B+3.3% | $2.7B-15.2% | $3.2B+12.1% | $2.8B+5.0% | $2.7B |
| Cash & Equivalents | $1.3B+31.3% | $962.0M-46.7% | $1.8B+19.7% | $1.5B+181.3% | $536.0M-43.9% | $955.0M+106.3% | $463.0M+5.5% | $439.0M-23.8% | $576.0M-9.7% | $638.0M-34.0% | $967.0M+24.0% | $780.0M-20.7% | $984.0M+2.6% | $959.0M+40.6% | $682.0M |
| Inventory | $2.2B-2.8% | $2.3B-3.1% | $2.4B-16.1% | $2.8B+84.3% | $1.5B+55.8% | $978.0M-5.8% | $1.0B-0.8% | $1.0B+16.2% | $900.0M+25.0% | $720.0M+5.6% | $682.0M-12.8% | $782.0M-2.7% | $804.0M+13.1% | $711.0M-0.1% | $712.0M |
| Accounts Receivable | $922.0M-17.8% | $1.1B-9.8% | $1.2B-9.9% | $1.4B+18.8% | $1.2B+46.6% | $792.0M-6.8% | $850.0M-16.4% | $1.0B+3.1% | $986.0M+23.1% | $801.0M+13.5% | $706.0M-11.9% | $801.0M-7.6% | $867.0M+4.8% | $827.0M-5.1% | $871.0M |
| Goodwill | $4.2B-22.6% | $5.4B-22.8% | $7.0B-2.3% | $7.1B+405.8% | $1.4B+21.1% | $1.2B+8.6% | $1.1B+1.6% | $1.1B+5.4% | $1.0B+26.0% | $796.0M+12.9% | $705.0M-5.9% | $749.0M-6.1% | $798.0M+2.7% | $777.0M+2.2% | $760.0M |
| Total Liabilities | $17.6B-0.4% | $17.7B-9.3% | $19.5B-5.3% | $20.6B+165.0% | $7.8B+5.5% | $7.4B+5.9% | $7.0B+10.1% | $6.3B-4.8% | $6.7B+15.3% | $5.8B-7.1% | $6.2B+3.8% | $6.0B-5.4% | $6.3B-13.1% | $7.3B+1.3% | $7.2B |
| Current Liabilities | $3.7B-5.3% | $3.9B-4.5% | $4.1B+0.1% | $4.1B+62.4% | $2.5B+27.0% | $2.0B+12.5% | $1.8B-1.4% | $1.8B+14.1% | $1.6B+44.8% | $1.1B-30.5% | $1.6B+15.8% | $1.3B-13.4% | $1.5B+14.0% | $1.4B-2.2% | $1.4B |
| Long-Term Debt | $11.4B+2.9% | $11.1B-9.9% | $12.3B-8.0% | $13.4B+321.1% | $3.2B-1.6% | $3.2B-5.3% | $3.4B+14.8% | $3.0B-10.4% | $3.3B+14.7% | $2.9B+17.1% | $2.5B-4.6% | $2.6B-10.4% | $2.9B-1.5% | $2.9B+2.0% | $2.9B |
| Total Equity | $4.0B-21.1% | $5.1B-27.4% | $7.1B+25.3% | $5.6B+34.6% | $4.2B+18.8% | $3.5B+40.6% | $2.5B-16.0% | $3.0B+3.4% | $2.9B+11.6% | $2.6B+8.8% | $2.4B-15.6% | $2.8B+4.4% | $2.7B+56.0% | $1.7B+29.0% | $1.3B |
| Retained Earnings | $9.9B-10.7% | $11.1B-14.5% | $12.9B+14.7% | $11.3B+16.5% | $9.7B+19.6% | $8.1B+26.4% | $6.4B+9.4% | $5.8B+18.8% | $4.9B+13.9% | $4.3B+19.3% | $3.6B+3.7% | $3.5B+15.9% | $3.0B+51.1% | $2.0B+19.8% | $1.7B |
CE Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $984.0M | $1.1B+18.6% | $966.0M-49.1% | $1.9B+4.4% | $1.8B+3.5% | $1.8B+30.8% | $1.3B-7.6% | $1.5B-6.7% | $1.6B+94.0% | $803.0M-10.1% | $893.0M+3.6% | $862.0M-10.4% | $962.0M+26.2% | $762.0M+5.5% | $722.0M+13.2% | $638.0M |
| Capital Expenditures | $276.0M | $343.0M-21.1% | $435.0M-23.4% | $568.0M+4.6% | $543.0M+16.3% | $467.0M+28.3% | $364.0M-1.6% | $370.0M+9.8% | $337.0M+26.2% | $267.0M+8.5% | $246.0M+6.0% | $232.0M-8.7% | $254.0M-8.3% | $277.0M-20.6% | $349.0M0.0% | $349.0M |
| Free Cash Flow | $708.0M | $803.0M+51.2% | $531.0M-60.1% | $1.3B+4.3% | $1.3B-1.1% | $1.3B+31.8% | $979.0M-9.7% | $1.1B-11.2% | $1.2B+127.8% | $536.0M-17.2% | $647.0M+2.7% | $630.0M-11.0% | $708.0M+46.0% | $485.0M+30.0% | $373.0M+29.1% | $289.0M |
| Investing Cash Flow | $203.0M | -$349.0M+25.7% | -$470.0M-250.7% | -$134.0M+98.8% | -$11.1B-895.6% | -$1.1B-289.0% | $592.0M+220.1% | -$493.0M+2.8% | -$507.0M+7.7% | -$549.0M-25.1% | -$439.0M+21.3% | -$558.0M+20.9% | -$705.0M-67.1% | -$422.0M+15.6% | -$500.0M-13.4% | -$441.0M |
| Financing Cash Flow | -$991.0M | -$513.0M+60.9% | -$1.3B+9.8% | -$1.5B-114.1% | $10.3B+1087.5% | -$1.0B+29.2% | -$1.5B-57.3% | -$935.0M+19.7% | -$1.2B-231.9% | -$351.0M+53.8% | -$759.0M-1050.0% | -$66.0M+84.1% | -$415.0M-27.3% | -$326.0M-765.3% | $49.0M+119.4% | -$253.0M |
| Dividends Paid | $13.0M | $13.0M-95.8% | $307.0M+0.7% | $305.0M+2.7% | $297.0M-2.3% | $304.0M+3.8% | $293.0M-2.3% | $300.0M+7.1% | $280.0M+16.2% | $241.0M+19.9% | $201.0M+15.5% | $174.0M+20.8% | $144.0M+73.5% | $83.0M+93.0% | $43.0M+26.5% | $34.0M |
| Share Buybacks | N/A | N/A | $0 | $0-100.0% | $17.0M-98.3% | $1.0B+53.8% | $650.0M-34.7% | $996.0M+23.7% | $805.0M+61.0% | $500.0M0.0% | $500.0M+19.0% | $420.0M+68.0% | $250.0M+52.4% | $164.0M+264.4% | $45.0M+45.2% | $31.0M |
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
CE Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 20.4%-2.3pp | 22.8%-0.9pp | 23.6%-1.0pp | 24.6%-6.8pp | 31.4%+8.6pp | 22.9%-2.6pp | 25.5%-2.1pp | 27.6%+2.9pp | 24.6%-1.5pp | 26.1%+2.8pp | 23.2%-0.5pp | 23.8%+2.8pp | 21.0%+2.6pp | 18.4%-2.8pp | 21.2% |
| Operating Margin | -8.2%-1.2pp | -7.0%-22.3pp | 15.2%+1.0pp | 14.2%-8.5pp | 22.8%+11.0pp | 11.7%-1.5pp | 13.2%-5.4pp | 18.6%+4.7pp | 14.0%-3.4pp | 17.3%+11.6pp | 5.8%-5.4pp | 11.1%-12.0pp | 23.2%+20.4pp | 2.7%-7.5pp | 10.2% |
| Net Margin | -12.2%+2.8pp | -15.0%-32.8pp | 17.8%-1.8pp | 19.6%-2.6pp | 22.1%-13.0pp | 35.1%+21.6pp | 13.5%-3.3pp | 16.9%+3.1pp | 13.7%-3.0pp | 16.7%+11.3pp | 5.4%-3.8pp | 9.2%-7.7pp | 16.9%+11.1pp | 5.8%-3.2pp | 9.0% |
| Return on Equity | -28.8%+1.3pp | -30.1%-57.6pp | 27.5%-6.1pp | 33.6%-11.5pp | 45.1%-11.2pp | 56.3%+22.3pp | 34.0%-6.5pp | 40.5%+11.3pp | 29.2%-5.6pp | 34.8%+22.0pp | 12.8%-9.4pp | 22.1%-18.6pp | 40.8%+19.3pp | 21.5%-23.8pp | 45.3% |
| Return on Assets | -5.4%+1.4pp | -6.8%-14.1pp | 7.3%+0.1pp | 7.2%-8.6pp | 15.8%-2.4pp | 18.2%+9.2pp | 9.0%-4.0pp | 13.0%+4.1pp | 8.8%-1.9pp | 10.8%+7.2pp | 3.5%-3.6pp | 7.1%-5.1pp | 12.2%+8.1pp | 4.1%-3.0pp | 7.1% |
| Current Ratio | 1.55+0.2x | 1.32-0.2x | 1.53-0.1x | 1.63+0.1x | 1.52-0.4x | 1.91+0.3x | 1.580.0x | 1.62-0.2x | 1.79-0.5x | 2.30+0.5x | 1.80-0.2x | 2.020.0x | 2.060.0x | 2.10+0.1x | 1.95 |
| Debt-to-Equity | 2.81+0.7x | 2.16+0.4x | 1.74-0.6x | 2.37+1.6x | 0.76-0.2x | 0.92-0.4x | 1.36+0.4x | 1.00-0.2x | 1.150.0x | 1.12+0.1x | 1.04+0.1x | 0.92-0.2x | 1.07-0.6x | 1.69-0.4x | 2.14 |
| FCF Margin | 8.4%+3.2pp | 5.2%-7.0pp | 12.2%-1.0pp | 13.2%-1.9pp | 15.1%-2.2pp | 17.3%+0.1pp | 17.2%+0.2pp | 17.1%+8.3pp | 8.7%-3.3pp | 12.0%+0.9pp | 11.1%+0.7pp | 10.4%+3.0pp | 7.4%+1.6pp | 5.8%+1.5pp | 4.3% |
Similar Companies
Where Celanese Corp Del Ranks
Frequently Asked Questions
What is Celanese Corp Del's annual revenue?
Celanese Corp Del (CE) reported $9.5B in total revenue for fiscal year 2025. This represents a -7.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Celanese Corp Del's revenue growing?
Celanese Corp Del (CE) revenue declined by 7.1% year-over-year, from $10.3B to $9.5B in fiscal year 2025.
Is Celanese Corp Del profitable?
No, Celanese Corp Del (CE) reported a net income of -$1.2B in fiscal year 2025, with a net profit margin of -12.2%.
What is Celanese Corp Del's EBITDA?
Celanese Corp Del (CE) had EBITDA of -$26.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Celanese Corp Del have?
As of fiscal year 2025, Celanese Corp Del (CE) had $1.3B in cash and equivalents against $11.4B in long-term debt.
What is Celanese Corp Del's gross margin?
Celanese Corp Del (CE) had a gross margin of 20.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Celanese Corp Del's operating margin?
Celanese Corp Del (CE) had an operating margin of -8.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Celanese Corp Del's net profit margin?
Celanese Corp Del (CE) had a net profit margin of -12.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Celanese Corp Del's return on equity (ROE)?
Celanese Corp Del (CE) has a return on equity of -28.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Celanese Corp Del's free cash flow?
Celanese Corp Del (CE) generated $803.0M in free cash flow during fiscal year 2025. This represents a 51.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Celanese Corp Del's operating cash flow?
Celanese Corp Del (CE) generated $1.1B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Celanese Corp Del's total assets?
Celanese Corp Del (CE) had $21.7B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Celanese Corp Del's capital expenditures?
Celanese Corp Del (CE) invested $343.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Celanese Corp Del spend on research and development?
Celanese Corp Del (CE) invested $125.0M in research and development during fiscal year 2025.
What is Celanese Corp Del's current ratio?
Celanese Corp Del (CE) had a current ratio of 1.55 as of fiscal year 2025, which is generally considered healthy.
What is Celanese Corp Del's debt-to-equity ratio?
Celanese Corp Del (CE) had a debt-to-equity ratio of 2.81 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Celanese Corp Del's return on assets (ROA)?
Celanese Corp Del (CE) had a return on assets of -5.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Celanese Corp Del's Altman Z-Score?
Celanese Corp Del (CE) has an Altman Z-Score of 1.24, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Celanese Corp Del's Piotroski F-Score?
Celanese Corp Del (CE) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Celanese Corp Del's earnings high quality?
Celanese Corp Del (CE) reported a net loss of $1.2B while generating $1.1B in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Celanese Corp Del cover its interest payments?
Celanese Corp Del (CE) reported an operating loss of $786.0M against $701.0M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Celanese Corp Del?
Celanese Corp Del (CE) scores 33 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.